The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.16
Bid: 3.52
Ask: 4.80
Change: 0.16 (4.00%)
Spread: 1.28 (36.364%)
Open: 4.00
High: 0.00
Low: 0.00
Prev. Close: 4.00
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK SMALLCAP ROUNDUP: African Minerals Gets $1.5B For Tonkolili

Tue, 13th Jul 2010 09:30

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps AFRICAN MINERALS LTD. (AMI.LN), an iron ore miner focused on Sierra Leone, Tuesday said it agreed a $1.5 billion investment in its Tonkolili project from Shandong Iron & Steel Group Co., in a deal that underscores China's appetite for raw materials to fuel its economic expansion. At 0804 GMT, shares +55.25 pence, or 14%, at 440.25 pence. INVISTA FOUNDATION PROPERTY TRUST LTD. (IFD.LN), a real estate investor, said it launched a share sale to strengthen its balance sheet and fund acquisitions. Invista said it intends to issue up to 32.3 million new shares to institutional investors in a type of share auction called a bookbuild. At 0804 GMT, shares +0.25 pence, or 0.6%, at 40.25 pence. MONITISE PLC (MONI.LN), a developer of banking services for mobile phones, said it is to raise GBP32.4 million through a share sale and announced an improved strategic partnership with Visa Inc. (V). At 0804 GMT, shares +1.75 pence, or 8.3%, at 22.75 pence. DUNELM GROUP PLC (DNLM.LN), a homeware retailer, said comparable sales growth slowed in its second half, and was marginally negative in the final ten weeks of the fiscal, although it expects full-year operating profit to be slightly higher than market expectations. At 0803 GMT, shares +13 pence, or 3.6%, at 371 pence. LUMINAR GROUP HOLDINGS PLC (LMR.LN), a nightclub operator, said the recent soccer World Cup tournament dented sales in its most recent 19 weeks' trading, with comparable sales plunging 19.9% in the period. At 0803 GMT, shares -1.5 pence, or 13%, at 10 pence. BTG PLC (BGC.LN), a pharmaceutical company, said it is putting the finishing touches on its plans to begin selling two emergency medicines in October. BTG acquired the rights to snake venom antidote CroFab and digoxin poisoning treatment DigiFab when it bought biotech peer Protherics PLC in 2008. BTG said it has hired senior sales and marketing staff, secured distributors and expects to have all the necessary sales licenses in place by August. At 0803 GMT, shares -1.3 pence, or 0.7%, at 200 pence. ARK THERAPEUTICS GROUP PLC (AKT.LN), a biotechnology company, said it is in talks with potential buyers of its wound care business. The company, which launched a strategic review after its experimental brain cancer medicine Cerepro was rejected by European drug regulators earlier this year, said a number of companies are completing due diligence on its wound care unit and negotiations are in progress. It added it is also in talks with potential strategic partners keen to make use of its Finland-based manufacturing facilities and said it is drawing up a plan for a U.S. clinical trial of Cerepro and is seeking a partner to pay for it. At 0802 GMT, shares flat at 4.88 pence. LOW & BONAR PLC (LWB.LN), a supplier of yarns and fabrics, reintroduced an interim dividend following a swing to a first-half pretax profit on the continued improvement in sales. At 0802 GMT, shares -5 pence, or 12%, at 38 pence. PROTEOME SCIENCES PLC (PRM.LN), a diagnostics company, said it developed two tests focused on aspects of Alzheimer's disease. At 0802 GMT, shares flat at 21.75 pence. INDIAN ENERGY LTD. (IEL.LN), a developer of wind farms in India, reported a wider fiscal-year loss due to the cost of joining the stock market, and said it is on track to hitting its target of being able to generate 300 megawatts of electricity by 2013. The company said it is evaluating new projects. Indian Energy added it agreed a GBP2 million loan from shareholder Utilico Emerging Markets Ltd. (UEM.LN) to pay for options on new wind projects. It said it is looking at ways to raise extra capital. At 0809 GMT, shares -4.25 pence, or 8.8%, at 44 pence. DTZ HOLDINGS PLC (DTZ.LN), a property consultant, posted a narrower fiscal-year loss following its strategic review and restructuring program, and said it plans to buy the remaining 20% stake of DTZ Asset Management Europe SAS that it doesn't already own. At 0809 GMT, shares +2 pence, or 3.3%, at 62.5 pence. DJ UK Smaller Cos +0.1% AIM +0.5% -By Jason Douglas, Hannah Benjamin and Rachael Gormley, Dow Jones Newswires; +44 (0) 20 7842 9272; uksmallcaps@dowjones.com (END) Dow Jones Newswires July 13, 2010 04:30 ET (08:30 GMT)
More News
25 Sep 2014 09:58

Proteome Unit Wins Alzheimer's Diagnostics Contract With Genting TauRx

Read more
8 Jul 2014 17:00

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Buys Shares

Read more
8 Jul 2014 11:22

REPEAT: UK MIDDAY BRIEFING: M&S Online Sales Slump On Website Move

Read more
8 Jul 2014 11:19

UK MIDDAY BRIEFING: M&S Sales Slump On Website Move

Read more
8 Jul 2014 10:42

UK WINNERS & LOSERS: Airline Stocks Nosedive On Air France-KLM Warning

Read more
8 Jul 2014 08:45

UPDATE 1-Study paves way for simple blood test to predict Alzheimer's

* Fatal brain-wasting disease has no effective treatments * Experts say drug failures may be due to late trials * Predictive test could find people before disease sets in * Shares in Proteome Sciences, involved in work, jump 12 pct (Adds Proteome Sciences stock move) By

Read more
8 Jul 2014 08:26

Proteome Sciences Publishes Study For Alzheimer's Blood Test

Read more
29 May 2014 10:22

Proteome Sciences Confident For Revenue Growth As Loss Narrows

LONDON (Alliance News) - Proteome Sciences PLC Thursday expressed confidence for continued fast revenue growth for the "forseeable future", as it posted a narrowed pretax loss for 2013, driven by strong sales of its Tandem Mass Tag reagents and growth in its biomarker assays. Proteome is en

Read more
27 Mar 2014 14:08

Proteome Says Study Using SysQuant Technology Demonstrates Its Potential

LONDON (Alliance News) - Proteome Sciences PLC said Thursday that a study using its SysQuant technology to address pancreatic cancer published in medical journal PLOS ONE demonstrated the potential of proteomics to improve the way that bespoke treatments can be made to match patients. Prote

Read more
28 Feb 2014 16:18

XP Power board members reduce holdings

XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t

Read more
24 Feb 2014 10:48

Proteome Sciences To Raise GBP5 Million In Share Placing

LONDON (Alliance News) - Proteome Sciences PLC said Monday it has placed 17.9 million new shares on the market to raise GBP5 million before expenses, with new and existing investors, which it will use for additional working capital. The protein biomarker company said the shares were placed

Read more
7 Feb 2014 10:06

Proteome edges ahead after flagging rise in revenue

Biotech group Proteome Sciences edged ahead after it revealed it expects revenue for 2013 to show "a significant increase" over 2012 thanks to strong performance across its core activities. The firm is an expert in biomarkers, or biological markers, that can help predict the likelihood of cancer r

Read more
7 Feb 2014 09:08

Proteome Sciences Says 2013 Revenues To Be Significantly Up

LONDON (Alliance News) - Shares in Proteome Sciences PLC rose in early trading Friday, after the protein biomarker company said revenue for 2013 will be significantly higher than the prior year, driven by a strong performance from all its core activities. Proteome is engaged in research an

Read more
4 Dec 2013 10:39

Proteome Sciences unveils sales delays, shares fall

Biotechnology group Proteome Sciences is facing sales delays that will push revenue from some deals into next year, hitting its shares. Proteome, which carries out research into protein and peptide biomarkers to treat neurological conditions and other illnesses such as cancer, said the timing and r

Read more
20 Nov 2013 10:55

Proteome Sciences Says Study Using Its Workflows Shows New Protein Biomarkers For Liver Cancer

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.